Johnson & Johnson (JNJ): Price and Financial Metrics

JNJ POWR Grades

• Quality is the dimension where JNJ ranks best; there it ranks ahead of 94.42% of US stocks.
• JNJ's strongest trending metric is Growth; it's been moving down over the last 177 days.
• JNJ's current lowest rank is in the Momentum metric (where it is better than 22.96% of US stocks).

JNJ Stock Summary

• JOHNSON & JOHNSON's market capitalization of $441,560,136,386 is ahead of 99.76% of US-listed equities.
• JNJ's went public 37.1 years ago, making it older than 93.53% of listed US stocks we're tracking.
• In terms of volatility of its share price, JNJ is more volatile than just 0.75% of stocks we're observing.
• Stocks that are quantitatively similar to JNJ, based on their financial statements, market capitalization, and price volatility, are XOM, UNH, TSM, LLY, and JPM.
• JNJ's SEC filings can be seen here. And to visit JOHNSON & JOHNSON's official web site, go to www.jnj.com.

JNJ Valuation Summary

• In comparison to the median Healthcare stock, JNJ's EV/EBIT ratio is 107.07% higher, now standing at 20.5.
• JNJ's price/earnings ratio has moved down 4.8 over the prior 243 months.

Below are key valuation metrics over time for JNJ.

JNJ Growth Metrics

Its 3 year revenue growth rate is now at 16.28%.
• The year over year cash and equivalents growth rate now stands at -17.43%.
• Its 4 year net income to common stockholders growth rate is now at 2.98%.

Over the past 67 months, JNJ's revenue has gone up $23,867,000,000.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	96,041	21,576	19,157
2022-06-30	95,588	23,582	18,366
2022-03-31	94,880	23,315	19,830
2021-12-31	93,775	23,410	20,878
2021-09-30	91,446	26,021	17,880
2021-06-30	89,190	26,114	17,767

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
• JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
• CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.